Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery
- PMID: 20182666
Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery
Abstract
Background and purpose: Increased risk for fungal infections has been observed in high-risk surgical patients, but the prognostic factors and impact of antifungal agents in this patient population are uncertain, especially in patients undergoing abdominal operation. This study was performed to ascertain the prognostic factors for patients with culture-positive Candida spp. who have had abdominal surgery.
Methods: From 2003 through 2006, all adult patients with positive candidal culture from abdominal specimens (peritoneal fluid obtained during laparotomy or drain effluent, abscess, or bile) at China Medical University Hospital, Taichung, Taiwan, were included in this retrospective study. Patients' demographic data, prognostic factors, and 30-day mortality rate related to fungal infection were analyzed by reviewing the medical charts.
Results: Thirty nine patients were enrolled in the study. The overall mortality rate was 35.9%. Candida albicans was the most common isolate (82.5%). The major prognostic factors were number of surgical interventions, Gram-negative bacteremia, high Acute Physiology And Chronic Health Evaluation (APACHE) II score, corticosteroid use, and subsequent candidal infection (p < 0.05).
Conclusions: In patients with positive intra-abdominal candidal culture, greater numbers of surgical intervention, Gram-negative bacilli bacteremia, and high APACHE II score were the prognostic factors for mortality. Corticosteroid use might be a risk factor for subsequent candidal infection.
Similar articles
-
Risk factors for candidemia-related mortality at a medical center in central Taiwan.J Microbiol Immunol Infect. 2006 Apr;39(2):155-61. J Microbiol Immunol Infect. 2006. PMID: 16604249
-
Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp.Clin Microbiol Infect. 2006 Feb;12(2):170-7. doi: 10.1111/j.1469-0691.2005.01318.x. Clin Microbiol Infect. 2006. PMID: 16441456
-
Fungemia in non-HIV-infected patients: a five-year review.Int J Infect Dis. 2009 Jan;13(1):90-6. doi: 10.1016/j.ijid.2008.04.009. Epub 2008 Jul 23. Int J Infect Dis. 2009. PMID: 18653367
-
[Candida species distribution in the patients with high risk of deep fungal infections and relevant risk factors: a prospective cohort study].Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2991-3. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18261333 Chinese.
-
Potential risk factors for infection with Candida spp. in critically ill patients.Clin Microbiol Infect. 2004 Jun;10(6):550-5. doi: 10.1111/j.1469-0691.2004.00873.x. Clin Microbiol Infect. 2004. PMID: 15191384
Cited by
-
Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.Clin Vaccine Immunol. 2011 Oct;18(10):1656-67. doi: 10.1128/CVI.05215-11. Epub 2011 Aug 10. Clin Vaccine Immunol. 2011. PMID: 21832099 Free PMC article.
-
Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.PLoS One. 2012;7(4):e35106. doi: 10.1371/journal.pone.0035106. Epub 2012 Apr 26. PLoS One. 2012. PMID: 22563378 Free PMC article.
-
Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.PLoS One. 2011;6(7):e22030. doi: 10.1371/journal.pone.0022030. Epub 2011 Jul 19. PLoS One. 2011. PMID: 21818288 Free PMC article.
-
Abolishing Cell Wall Glycosylphosphatidylinositol-Anchored Proteins in Candida albicans Enhances Recognition by Host Dectin-1.Infect Immun. 2015 Jul;83(7):2694-704. doi: 10.1128/IAI.00097-15. Epub 2015 Apr 20. Infect Immun. 2015. PMID: 25895969 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous